Latin America, Middle East & Africa Biosurgery Market (2019-2025)
The Latin America, Middle East and Africa Biosurgery Market would witness market growth of 7.4% CAGR during the forecast period (2019-2025).
Biological products can be used in several applications in orthopedic surgeries. Postoperative blood loss is a crucial issue that leads to a high rate of mortality. In order to prevent excessive blood loss at the time of hip and knee arthroplasty, hemostatic agents like intravenous tranexamic acid are used. The biosurgery market has been projected to benefit from enormous latent opportunities in an increased number of surgeries across the world. A wide range of surgeries is meant to treat sports-related and severe trauma injuries. The market is also expected to bring in significant gains from the rapidly aging population in the emerging countries.
Biosurgery applications are used to treat a wide range of ailments. Neurosurgery and spine surgery treats diseases concerned with the nervous system. It includes the spinal cord, brain, peripheral nervous system, as well as extra-cranial cerebrovascular system. Cardiovascular and thoracic surgical treatments can be conducted for diseases that are associated with coronary arteries, heart, major blood vessels, lungs, chest, and esophagus.
The Latin America Bio Surgery market's main driver is the increased approval by regulatory authorities of biosurgery products. Furthermore, the rising number of surgeries, increasing geriatric populations, changes in lifestyle and increasing need for effective management of blood loss, supports the region's market growth. However, there are little-to-no reimbursements for products of biosurgery and the associated costs are usually too high to be used by the general public. This in general, together with the rising costs of surgical procedures, acts as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
Biological products can be used in several applications in orthopedic surgeries. Postoperative blood loss is a crucial issue that leads to a high rate of mortality. In order to prevent excessive blood loss at the time of hip and knee arthroplasty, hemostatic agents like intravenous tranexamic acid are used. The biosurgery market has been projected to benefit from enormous latent opportunities in an increased number of surgeries across the world. A wide range of surgeries is meant to treat sports-related and severe trauma injuries. The market is also expected to bring in significant gains from the rapidly aging population in the emerging countries.
Biosurgery applications are used to treat a wide range of ailments. Neurosurgery and spine surgery treats diseases concerned with the nervous system. It includes the spinal cord, brain, peripheral nervous system, as well as extra-cranial cerebrovascular system. Cardiovascular and thoracic surgical treatments can be conducted for diseases that are associated with coronary arteries, heart, major blood vessels, lungs, chest, and esophagus.
The Latin America Bio Surgery market's main driver is the increased approval by regulatory authorities of biosurgery products. Furthermore, the rising number of surgeries, increasing geriatric populations, changes in lifestyle and increasing need for effective management of blood loss, supports the region's market growth. However, there are little-to-no reimbursements for products of biosurgery and the associated costs are usually too high to be used by the general public. This in general, together with the rising costs of surgical procedures, acts as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Biosurgery Market, by Application
1.4.2 LAMEA Biosurgery Market, by Product
1.4.3 LAMEA Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. LAMEA BIOSURGERY MARKET BY APPLICATION
4.1 LAMEA General Surgeries Market by Country
4.2 LAMEA Orthopedic Surgeries Market by Country
4.3 LAMEA Neurological Surgeries Market by Country
4.4 LAMEA Cardiovascular Surgeries Market by Country
4.5 LAMEA Other Application Biosurgery Market by Country
CHAPTER 5. LAMEA BIOSURGERY MARKET BY PRODUCT
5.1 LAMEA Surgical sealants Biosurgery Market by Country
5.2 LAMEA Soft Tissue Attachments Biosurgery Market by Country
5.3 LAMEA Adhesion Barriers Biosurgery Market by Country
5.4 LAMEA Hemostatic Agents Biosurgery Market by Country
5.5 LAMEA Bone Graft Substitutes Biosurgery Market by Country
5.6 LAMEA Others Biosurgery Market by Country
CHAPTER 6. LAMEA BIOSURGERY MARKET BY COUNTRY
6.1 Brazil Biosurgery Market
6.1.1 Brazil Biosurgery Market by Application
6.1.2 Brazil Biosurgery Market by Product
6.2 Argentina Biosurgery Market
6.2.1 Argentina Biosurgery Market by Application
6.2.2 Argentina Biosurgery Market by Product
6.3 UAE Biosurgery Market
6.3.1 UAE Biosurgery Market by Application
6.3.2 UAE Biosurgery Market by Product
6.4 Saudi Arabia Biosurgery Market
6.4.1 Saudi Arabia Biosurgery Market by Application
6.4.2 Saudi Arabia Biosurgery Market by Product
6.5 South Africa Biosurgery Market
6.5.1 South Africa Biosurgery Market by Application
6.5.2 South Africa Biosurgery Market by Product
6.6 Nigeria Biosurgery Market
6.6.1 Nigeria Biosurgery Market by Application
6.6.2 Nigeria Biosurgery Market by Product
6.7 Rest of LAMEA Biosurgery Market
6.7.1 Rest of LAMEA Biosurgery Market by Application
6.7.2 Rest of LAMEA Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Biosurgery Market, by Application
1.4.2 LAMEA Biosurgery Market, by Product
1.4.3 LAMEA Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. LAMEA BIOSURGERY MARKET BY APPLICATION
4.1 LAMEA General Surgeries Market by Country
4.2 LAMEA Orthopedic Surgeries Market by Country
4.3 LAMEA Neurological Surgeries Market by Country
4.4 LAMEA Cardiovascular Surgeries Market by Country
4.5 LAMEA Other Application Biosurgery Market by Country
CHAPTER 5. LAMEA BIOSURGERY MARKET BY PRODUCT
5.1 LAMEA Surgical sealants Biosurgery Market by Country
5.2 LAMEA Soft Tissue Attachments Biosurgery Market by Country
5.3 LAMEA Adhesion Barriers Biosurgery Market by Country
5.4 LAMEA Hemostatic Agents Biosurgery Market by Country
5.5 LAMEA Bone Graft Substitutes Biosurgery Market by Country
5.6 LAMEA Others Biosurgery Market by Country
CHAPTER 6. LAMEA BIOSURGERY MARKET BY COUNTRY
6.1 Brazil Biosurgery Market
6.1.1 Brazil Biosurgery Market by Application
6.1.2 Brazil Biosurgery Market by Product
6.2 Argentina Biosurgery Market
6.2.1 Argentina Biosurgery Market by Application
6.2.2 Argentina Biosurgery Market by Product
6.3 UAE Biosurgery Market
6.3.1 UAE Biosurgery Market by Application
6.3.2 UAE Biosurgery Market by Product
6.4 Saudi Arabia Biosurgery Market
6.4.1 Saudi Arabia Biosurgery Market by Application
6.4.2 Saudi Arabia Biosurgery Market by Product
6.5 South Africa Biosurgery Market
6.5.1 South Africa Biosurgery Market by Application
6.5.2 South Africa Biosurgery Market by Product
6.6 Nigeria Biosurgery Market
6.6.1 Nigeria Biosurgery Market by Application
6.6.2 Nigeria Biosurgery Market by Product
6.7 Rest of LAMEA Biosurgery Market
6.7.1 Rest of LAMEA Biosurgery Market by Application
6.7.2 Rest of LAMEA Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
LIST OF TABLES
TABLE 1 LAMEA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 LAMEA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 LAMEA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 LAMEA GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 LAMEA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 LAMEA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 LAMEA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 LAMEA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 LAMEA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 LAMEA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 LAMEA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 LAMEA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 LAMEA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 LAMEA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 LAMEA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 LAMEA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 LAMEA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 LAMEA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 LAMEA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 LAMEA OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 LAMEA OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 LAMEA BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 LAMEA BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 BRAZIL BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 BRAZIL BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 BRAZIL BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 BRAZIL BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 BRAZIL BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 BRAZIL BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 ARGENTINA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 ARGENTINA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 ARGENTINA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 ARGENTINA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 ARGENTINA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 ARGENTINA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 UAE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 UAE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 UAE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 UAE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 UAE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 UAE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 SAUDI ARABIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 SAUDI ARABIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 SOUTH AFRICA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 60 SOUTH AFRICA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 61 SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 64 SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 65 NIGERIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 66 NIGERIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 67 NIGERIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 NIGERIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 NIGERIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 70 NIGERIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 71 REST OF LAMEA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 72 REST OF LAMEA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 73 REST OF LAMEA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 REST OF LAMEA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 REST OF LAMEA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 76 REST OF LAMEA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 77 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 78 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 79 KEY INFORMATION – MEDTRONIC PLC
TABLE 80 KEY INFORMATION – PFIZER, INC.
TABLE 81 KEY INFORMATION – STRYKER CORPORATION
TABLE 82 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 83 KEY INFORMATION – SANOFI S.A.
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 86 KEY INFORMATION – CSL LIMITED
TABLE 1 LAMEA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 LAMEA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 LAMEA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 LAMEA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 LAMEA GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 LAMEA GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 LAMEA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 LAMEA ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 LAMEA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 LAMEA NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 LAMEA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 LAMEA CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 LAMEA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 LAMEA OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 LAMEA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 LAMEA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 LAMEA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 LAMEA SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 LAMEA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 LAMEA SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 LAMEA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 LAMEA ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 LAMEA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 LAMEA HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 LAMEA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 LAMEA BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 LAMEA OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 LAMEA OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 LAMEA BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 LAMEA BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 BRAZIL BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 BRAZIL BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 BRAZIL BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 BRAZIL BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 BRAZIL BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 BRAZIL BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 ARGENTINA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 ARGENTINA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 ARGENTINA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 ARGENTINA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 ARGENTINA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 ARGENTINA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 UAE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 UAE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 UAE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 UAE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 UAE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 UAE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 SAUDI ARABIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 SAUDI ARABIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 SAUDI ARABIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 SAUDI ARABIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 SOUTH AFRICA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 60 SOUTH AFRICA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 61 SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SOUTH AFRICA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 64 SOUTH AFRICA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 65 NIGERIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 66 NIGERIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 67 NIGERIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 NIGERIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 NIGERIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 70 NIGERIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 71 REST OF LAMEA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 72 REST OF LAMEA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 73 REST OF LAMEA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 REST OF LAMEA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 REST OF LAMEA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 76 REST OF LAMEA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 77 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 78 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 79 KEY INFORMATION – MEDTRONIC PLC
TABLE 80 KEY INFORMATION – PFIZER, INC.
TABLE 81 KEY INFORMATION – STRYKER CORPORATION
TABLE 82 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 83 KEY INFORMATION – SANOFI S.A.
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 86 KEY INFORMATION – CSL LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
